Advocacy Wealth Management Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2M Sell
21,869
-193
-0.9% -$197K 0.95% 26
2026
Q1
$20.3M Sell
22,062
-1,558
-7% -$1.58M 0.9% 28
2025
Q4
$25.4M Sell
23,620
-785
-3% -$751K 1.06% 24
2025
Q3
$18.6M Buy
+24,405
New +$18.2M 0.81% 34
2022
Q4
Sell
-5
Closed -$2K 90
2022
Q3
$2K Hold
5
﹤0.01% 112
2022
Q2
$2K Hold
5
﹤0.01% 120
2022
Q1
$1K Hold
5
﹤0.01% 169
2021
Q4
$1K Hold
5
﹤0.01% 169
2021
Q3
$1K Hold
5
﹤0.01% 162
2021
Q2
$1K Buy
+5
New +$1K ﹤0.01% 177
2016
Q2
Sell
-865
Closed -$62K 429
2016
Q1
$62K Sell
865
-850
-50% -$64.3K 0.04% 166
2015
Q4
$144K Buy
+1,715
New +$142K 0.16% 99
2013
Q3
$139K Sell
2,756
-600
-18% -$31.4K 0.38% 51
2013
Q2
$165K Buy
+3,356
New +$183K 0.66% 46

Other funds holding LLY

Advocacy Wealth Management Services's LLY Position: Q2 2026 in Review

Advocacy Wealth Management Services reduced its Eli Lilly (LLY) stake by 0.87% in Q2 2026, selling an estimated $197K and leaving 21,869 shares worth $26.2M. The position accounts for 0.95% of the portfolio, ranked #26.

Advocacy Wealth Management Services first reported a position in LLY in Q2 2013 and has held it in 14 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Advocacy Wealth Management Services held 21,869 shares of Eli Lilly worth $26.2M as of Q2 2026.
  • Advocacy Wealth Management Services sold 193 Eli Lilly shares in Q2 2026, an estimated $197K.
  • Eli Lilly made up 0.95% of Advocacy Wealth Management Services's portfolio in Q2 2026, its #26 holding.
  • Advocacy Wealth Management Services first reported a position in Eli Lilly in Q2 2013 and has held it in 14 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Advocacy Wealth Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.